This study is the first to demonstrate that compound <b>17</b> exerts potent anti-lung cancer activity by targeting the TNF signaling pathway and activating the mitochondrial apoptosis pathway, providing a critical experimental foundation for its development as a novel therapeutic agent against lung cancer. This evidence concerns the gene TNF and lung cancer.